Vaginal Health in Menopausal Women.
Stefania Alvisi, Giulia Gava, Isabella Orsili...
https://pubmed.ncbi.nlm.nih.gov/31547180/Actively Recruiting
Led by University of Sao Paulo General Hospital · Updated on 2026-03-03
60
Participants Needed
1
Research Sites
17 weeks
Total Duration
Sjf6grens disease SjD is a chronic inflammatory condition mainly affecting the salivary and lacrimal glands, leading to dryness symptoms. It mostly affects women between 40 and 60 years old and causes vaginal dryness symptoms that impact quality of life. There are currently no specific treatments for vaginal dryness in SjD, though similar symptoms in menopausal women can be treated with hormone therapy or vaginal fractional CO2 laser, which has shown safety and effectiveness in other conditions. This study is a 6-month randomized clinical trial comparing two treatments for vaginal dryness in SjD patients vaginal fractional CO2 laser therapy and topical promestriene. Sixty women with SjD and vaginal dryness will be split evenly into two groups. The laser group will receive monthly laser treatments for three months, while the promestriene group will apply vaginal capsules nightly for 15 days, then every three days until six months of treatment is completed. Participants will be monitored over the study period with evaluations at four and six months after starting treatment. Assessments include vaginal health, sexual function, quality of life, urinary symptoms, and vaginal dryness severity. Safety will be checked monthly during treatment and at follow-up visits. The study aims to measure improvements in vaginal health and symptom relief while tracking any side effects, with total participation lasting six months.
CONDITIONS
TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE
E
Eloisa Bonfa, Full prof.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Sao Paulo General Hospital
Lead Sponsor
Fundação de Amparo à Pesquisa do Estado de São Paulo
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants are treated with either vaginal fractional CO2 laser or topical promestriene to address vaginal dryness in Sjögren's disease.
3 monthly visits for laser applications or ongoing use of promestriene capsules over 6 months with periodic assessments
Duration - Up to 6 months from treatment start
Participants are monitored for treatment effects and safety after treatment completion.
Monthly visits for safety assessments up to 6 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Stefania Alvisi, Giulia Gava, Isabella Orsili...
https://pubmed.ncbi.nlm.nih.gov/31547180/Raphaèle Seror, Philippe Ravaud, Simon J Bowman...
https://pubmed.ncbi.nlm.nih.gov/19561361/Maurizio Filippini, Irene Porcari, Alessandro F Ruffolo...
https://pubmed.ncbi.nlm.nih.gov/35101378/José Tadeu Nunes Tamanini, Miriam Dambros, Carlos Arturo Levi D'Ancona...
https://pubmed.ncbi.nlm.nih.gov/15243675/Samira Tatiyama Miyamoto, Maurício Aquino Paganotti, Érica Vieira Serrano...
https://pubmed.ncbi.nlm.nih.gov/25582994/Claudette A Farenhorst, Liseth de Wolff, Suzanne Arends...
https://pubmed.ncbi.nlm.nih.gov/34665706/Angelika Lackner, Martin H Stradner, Josef Hermann...
https://pubmed.ncbi.nlm.nih.gov/29395257/Julene B Samuels, Martin A Garcia
https://pubmed.ncbi.nlm.nih.gov/29726916/Andrea M Isidori, Carlotta Pozza, Katherine Esposito...
https://pubmed.ncbi.nlm.nih.gov/19968774/Murat Gözüküçük, Esengül Türkyilmaz, Orhan Küçükşahin...
https://pubmed.ncbi.nlm.nih.gov/34665702/University of Sao Paulo General Hospital
Lead Sponsor
Fundação de Amparo à Pesquisa do Estado de São Paulo
Collaborating Sponsor